---
title: "APT: Net profit in the first half of 2025 increased by 24.11% year-on-year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253992253.md"
description: "APT announced that its operating revenue in the first half of 2025 was 1.214 billion yuan, a year-on-year increase of 21.26%. Net profit was 425 million yuan, a year-on-year increase of 24.11%"
datetime: "2025-08-21T12:12:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253992253.md)
  - [en](https://longbridge.com/en/news/253992253.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253992253.md)
---

# APT: Net profit in the first half of 2025 increased by 24.11% year-on-year

APT announced that its operating revenue in the first half of 2025 was 1.214 billion yuan, a year-on-year increase of 21.26%. Net profit was 425 million yuan, a year-on-year increase of 24.11%

### Related Stocks

- [688617.CN](https://longbridge.com/en/quote/688617.CN.md)

## Related News & Research

- [Comey eyes new 'anti-weaponization' fund: 'I'm guessing I'll be in line'](https://longbridge.com/en/news/286948735.md)
- [Trump faces record-low approval on inflation as retirees struggle](https://longbridge.com/en/news/286834439.md)
- [09:06 ETHarmony Comes to the Massachusetts State House as The Platters® Prepare Their Musical Love Letter to the World](https://longbridge.com/en/news/286918739.md)
- [13:41 ETUT Haslam Marks Decade in Major International Ranking's Top Five U.S. Public Schools](https://longbridge.com/en/news/286804132.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)